Best Clinical Labs IT Companies in United Kingdom
The 106 best Clinical Labs IT companies in United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Automata.
Ranking the most-funded Clinical Labs IT companies in the United Kingdom, this directory tracks 106 firms against $465M in total disclosed equity, ordered by funding size and recent momentum. Automata leads at $107M raised, followed by Brainomix at $35M and Cirdan Imaging at $24M. No unicorns yet, but the funding concentration tells you something: three companies account for well over a third of the entire pool. The [global clinical labs IT market sat at $203.3B in 2022 and is forecast to reach $391.1B by 2028](https://maximizemarketresearch.com), a 4.9% CAGR that's pulling capital into the sector steadily. Personalised medicine and RNA sequencing are the demand engines, and as shown in 2016 research, advances in analytical instrumentation have fundamentally reshaped what labs can process at scale.
So what does this mean for UK-specific plays? Coverage across the sector is visibly rising, with vaccine preclinical testing and post-Covid complication monitoring driving new filing activity. I'd note that investors like EIC Fund and Oxford University Innovation signal a deliberate tilt toward scientifically de-risked, IP-backed businesses rather than pure software bets. Regulatory scrutiny on diagnostics in the UK has tightened post-Brexit, which raises the bar for new entrants but rewards companies with validated clinical evidence. The funding's real, the market's growing, and the directory below gives you the clearest financial picture available.
- Frost & Sullivan
- maximizemarketresearch.com
Ranked: Best Clinical Labs IT companies in United Kingdom
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Automata Developer of modular lab automation platforms for biological research workflows 64Funding top 25%Product top 25%Tech top 27%Moat top 31% All 11 signals ▾Fundingtop 25% Producttop 25% Techtop 27% Moattop 31% Innovationtop 32% Fin. healthtop 33% Newstop 43% Growthtop 48% Talentbottom 49% Marketbottom 44% Globalbottom 39% Funding: Raised $107M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) Product: 7 distinct product lines · Company stage: Series C rank vs industry peers · Fliar Intelligence Index 64/100 | $107M | 4 mo ago | 40 | Mostafa ElSayed Co-Founder & CEO | WordPress Block EditorWordPressApple iCloud Mail+33 | — | 1 partnership |
| 2 | Synthace Developer of software for automating biological experiments and data analysis | $80M | 55 mo ago | 68 68 → 36 (-47%) · sector median +10% | Markus Gershater Co-Founder & CEO | HubSpot CMS HubApple iCloud MailGoogle Workspace+20 | 26 patents Automated laboratory and bioprocess workflows, including liquid handling and data integration. | — |
| 3 | NuGenesis Lab Management Provider of lab management system | $40M | 285 mo ago | 140 | Chris O'Connell CEO | — | — | — |
| 4 | Brainomix Developer of automated medical imaging software for stroke and lung 64AI top 18%Funding top 28%Patents top 31%Fin. health top 35% All 13 signals ▾AItop 18% Fundingtop 28% Patentstop 31% Fin. healthtop 35% Producttop 40% Innovationtop 42% Growthtop 46% Moattop 46% Techtop 47% Talentbottom 49% Marketbottom 45% Globalbottom 45% Newsbottom 37% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Funding: Raised $34.8M across 8 rounds · 8 rounds over 12 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 64/100 | $35M | 7 mo ago | 29 | Michalis Papadakis Co-Founder & CEO | Apple iCloud MailMicrosoft 365Salesforce+27 | 19 patents AI-driven quantitative analysis of medical imaging for lung disease and lesion assessment | — |
| 5 | Kheiron Med Developer of AI-powered health informatics solutions for diagnostic and screening programs | $31M | 70 mo ago | 37 | Peter Kecskemethy Co-founder and CEO | WordPress Block EditorWordPressApple iCloud Mail+23 | — | — |
| 6 | Cirdan Imaging Laboratory Information System for clinical laboratories 53Product top 30%Growth top 31%Moat top 37%Talent top 38% All 12 signals ▾Producttop 30% Growthtop 31% Moattop 37% Talenttop 38% Fundingtop 39% Fin. healthtop 45% Techbottom 47% Marketbottom 46% Globalbottom 45% Innovationbottom 44% Patentsbottom 33% Newsbottom 20% Product: 4 distinct product lines · Company stage: Series B Growth: Revenue +39% YoY · Web rank 50,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 53/100 | $24M | 2 mo ago | 84 | Cahal Cormican Co-Founder | WordPressMySQLPHP+18 | 6 patents Patents concentrated in health & consumer products | — |
| 7 | Medica Provider of teleradiology and communication services for healthcare organizations and professionals | $22M | 62 mo ago | 306 306 → 316 (+3%) · sector median +10% | Stuart Quin CEO | WordPressMySQLPHP+39 | 16 patents Protective medical eyewear, surgical head supports, and AR imaging for operative assistance | — |
| 8 | Optellum Provider of AI-based cancer diagnostics platform | $21M | 44 mo ago | 28 28 → 52 (+86%) · sector median +10% | Timor Kadir Co-Founder & CTO | WordPressMySQLPHP+29 | 60 patents AI-powered medical imaging analysis and predictive analytics for oncology outcomes | 2 partnerships |
| 9 | Caristo Diagnostics Developer of technology for cardiac disease risk assessment and analysis | $19M | 38 mo ago | 20 | Stefan Neubauer Co-Founder | WordPressMySQLPHP+27 | 4 patents Radiomic analysis of medical imaging for vascular disease detection and risk assessment | 2 awards |
| 10 | IXICO AI-based medical image management and analysis solutions for healthcare organizations 64Funding top 32%Growth top 40%Fin. health top 40%Moat top 42% All 10 signals ▾Fundingtop 32% Growthtop 40% Fin. healthtop 40% Moattop 42% Techtop 44% Markettop 45% AItop 45% Innovationbottom 47% Patentsbottom 42% Globalbottom 42% Funding: Raised $10.3M across 5 rounds · 5 rounds over 14 yrs (0.4/yr) Growth: Headcount 82 → 93 (+13%) across vintages · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 64/100 | $10M | 19 mo ago | 93 93 → 93 (+0%) · sector median +10% | — | SilverstripePHPDebian+19 | 10 patents Medical imaging data integrity, management, and fraud detection for healthcare diagnostics | — |
| 11 | Skin Analytics Provider of smartphone based skin cancer detection 72AI top 18%Growth top 21%Product top 30%Innovation top 32% All 12 signals ▾AItop 18% Growthtop 21% Producttop 30% Innovationtop 32% Patentstop 34% Moattop 37% Fundingtop 38% Techtop 48% Talentbottom 49% Marketbottom 42% Globalbottom 42% Newsbottom 21% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Growth: Headcount 19 → 42 (+121%) across vintages · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 72/100 | $10M | 14 mo ago | 42 | Neil Daly Founder & CEO | WordPressMySQLPHP+26 | 16 patents Dermatology imaging device validation and AI classifier calibration for skin diagnostics | 1 launch |
| 12 | Intelligent Ultrasound Ultrasound imaging analytics platform for improving image quality and operational efficency | $10M | 74 mo ago | 7 | Stuart Gall CEO | WordPress Block EditorElementorCart Functionality+22 | 27 patents Advanced ultrasound imaging and fetal diagnostics, including tube positioning and procedure monitoring. | — |
| 13 | Mirada Medical Software products that use medical images to diagnose and treat cancer | $8M | 86 mo ago | 81 81 → 42 (-48%) · sector median +10% | Hugh Bettesworth Founder & Director | — | 99 patents AI-driven medical imaging analysis, uncertainty quantification, and radiotherapy planning tools. | 2 job openings |
| 14 | Peak Analysis and Automation Developer of laboratory automation robotics for the pharmaceutical & biotechnology industries | $6M | 150 mo ago | 78 | — | — | 5 patents Robotic positioning systems for precision manufacturing and automated assembly processes. | 4 launchs |
| 15 | Optasia Medical Software for analyzing X-ray images | $6M | 233 mo ago | 7 | — | — | — | — |
| 16 | Overwatch Research Online platform for clinical trial data and workflow management | $4M | 57 mo ago | 6 | Paul Wilsdon Co-Founder | — | — | — |
| 17 | PicturaBio Provider of digital imaging platform for the detection of pathogens | $4M | 36 mo ago | 5 | Alex Batchelor Co-Founder & CEO | — | — | 1 job opening |
| 18 | Tenyks AI-based medical imaging and diagnostic tools providers | $4M | 51 mo ago | 3 | — | WebflowGSAPHubSpot+17 | — | — |
| 19 | OxDX AI-based pathogen detection tool for sample analysis | $4M | 52 mo ago | 6 | — | — | — | — |
| 20 | DynamX Medical Provider of a biopsy screening medical device targeting cancer and other diseases | $3M | 94 mo ago | 7 | Katherine Willetts Co-Founder | — | — | — |
| 21 | Sierra Medical AI-powered healthcare software for early cancer detection | $3M | 48 mo ago | 6 | Liberty Foreman Founder & CEO | — | — | — |
| 22 | Neuranics Developer of magnetic sensing technology for next-generation wearable systems 21Talent top 38%Growth top 45%Moat top 47%Funding bottom 47% All 10 signals ▾Talenttop 38% Growthtop 45% Moattop 47% Fundingbottom 47% Patentsbottom 41% Globalbottom 40% Innovationbottom 31% Techbottom 31% Marketbottom 27% Newsbottom 21% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 21/100 | $2M | 14 mo ago | 10 | Hadi Heidari Co-Founder & CTO | WordPressMySQLPHP+17 | 2 patents Continuous cardiac arrhythmia monitoring using wearable sensor technology | 1 launch · 1 partnership |
| 23 | Blackford Analysis Provider of image comparison and analysis software | $2M | 124 mo ago | 35 35 → 56 (+60%) · sector median +10% | — | HubSpot CMS HubVideoJSEnvoy+18 | 28 patents Automated metadata-driven medical image analysis and routing for anatomy identification. | 1 launch |
| 24 | GSP Developer of medical devices for quantitative medical imaging | $2M | 48 mo ago | 3 | Aaron Taylor Co-Founder & CTO | — | — | — |
| 25 | Envisionit Deep AI Developer of an AI assurance platform for medical imaging analysis | $2M | 39 mo ago | 12 | Andrei Migatchev Co-Founder And Cto | WordPressMySQLPHP+16 | — | 1 award |
| 26 | PathXL Develops web-based workflow solutions for digital pathology | $1M | 163 mo ago | 30 | Des Speed ex-CEO | — | 25 patents Digital pathology image analysis and tissue recognition with artifact correction and normalization | — |
| 27 | Briefly Platform to capture and share lab work reproducibly | $1M | 23 mo ago | — | Katya Putintseva Co-Founder | — | — | — |
| 28 | Digistain Provider of image-based cancer diagnosis solutions | $1M | 46 mo ago | 1 | — | WordPressMySQLPHP+23 | — | — |
| 29 | Acuitas Medical Analysis software for magnetic resonance imaging | $1M | 180 mo ago | 3 | John Heinrich CEO | — | 30 patents Advanced MRI acquisition and motion‑correction techniques for high‑resolution fine‑structure imaging | — |
| 30 | Lab Thread Developer of a software platform for streamlining laboratory research and data | $1M | 11 mo ago | — | Deyan Sultov Co-Founder & CTO | — | — | 2 launchs |
| 31 | Sime Dx Point-of-care digital digital diagnostics | $971K | 73 mo ago | 8 | Povl Verder Founder & CEO | — | — | — |
| 32 | Motilent Provider of medical imaging platform for gastrointestinal conditions | $906K | 48 mo ago | — | Alex Menys Founder & CEO | PHPNginxAmazon Web Services+6 | 6 patents Medical imaging analysis for gastrointestinal tract motion, segmentation, and fistula morphology | — |
| 33 | BiologIC Provider of platform and instruments for research | $727K | 35 mo ago | 8 | — | — | — | 1 launch |
| 34 | TexRAD Medical image analysis software for cancer risk assessment, prognosis & diagnosis | $389K | 114 mo ago | 40 | — | — | 6 patents Medical image texture analysis for diagnostic radiology | — |
| 35 | Spotlight Pathology Developer of AI-powered decision support tools for blood cancer diagnosis 37AI top 35%Talent top 38%Funding bottom 47%Growth bottom 42% All 7 signals ▾AItop 35% Talenttop 38% Fundingbottom 47% Growthbottom 42% Marketbottom 37% Globalbottom 29% Newsbottom 21% AI: Product described with: ai-powered, machine learning Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 37/100 | $162K | 3 mo ago | — | Richard Byers Co-Founder | — | — | — |
| 36 | Opvia Cloud-based platform for document collaboration | $150K | 69 mo ago | 7 | — | — | — | 8 job openings |
| 37 | Segmentum Analysis Provider of software for imaging in digital pathology | $110K | 81 mo ago | 1 | Matthew Williams CEO | — | — | — |
| 38 | AI-Sight AI-based solution for diabetic retinal screening | — | 21 mo ago | — | Steven Powell CEO | — | — | — |
| 39 | Titian Software Digital sample management platform for researchers | — | 48 mo ago | 71 71 → 83 (+17%) · sector median +10% | — | — | — | — |
Top 12 Clinical Labs IT companies in United Kingdom
#1
Series C · London, England · founded 2015 · 40 employees$106.5Mraised▾
Developer of modular lab automation platforms for biological research workflows. This system integrates hardware and software to orchestrate laboratory processes, including sample handling and instrument management. The platform utilizes node-based design tools and software development kits to enable workflow configuration and simulation. It supports connectivity with external data systems and analytical models to facilitate automated execution of experimental protocols. The hardware components are configurable to accommodate various instruments and laboratory layouts, allowing for the management of multiple concurrent tasks.
- Jan 2026Series C$45M
- Oct 2023Series B$40M
- Feb 2022Series B$50M
- Mar 2019Series A$7.4M
#2
Series B · Lisburn, Northern Ireland · founded 2010 · 84 employees$23.6Mraised▾
Cirdan Imaging designs manufactures and supplies medical imaging & informatics technology for the medical diagnosis and treatment of cancer. The company offers VividPath, a PACS image acquisition and viewer workstation to acquire, view, annotate, report, and store images in a database. Also provides gross specimen macro imaging systems for pathology laboratories; digital microscope cameras to support live onscreen review and image capture of slides; and medical imaging software solutions. The company has additional offices in Canada and Australia and offers products through a network of distributors in Europe, the Middle East, and Africa.
- Apr 2026Series B$4M
- Apr 2026Venture Debt$5.4M
- Oct 2024Series B$9.8M
- Oct 2023Series A$2.8M
#3
Series C · Oxford, England · founded 2010 · 29 employees$34.8Mraised▾
Developer of automated medical imaging software for stroke and lung. This technology processes medical scans to identify biomarkers and assist in clinical assessment. The software provides automated analysis for stroke detection and lung disease evaluation. These tools support diagnostic workflows by generating insights from imaging data to assist in treatment decisions.
- Oct 2025Series C$6.5M
- Jan 2025Series C$18M
- May 2023Series B—
- Dec 2021Series B$21.7M
#4
Series B · Salisbury, England · founded 2012 · 42 employees$10.1Mraised▾
Provider of smartphone-based skin cancer detection. The company has developed is a cloud-based solution that helps in the early detection of skin cancer by analyzing any change in the size or shape of a mole. It consists of a mobile camera attachment which takes clinical-quality images and processes them using image algorithms for diagnosis. Skin Analytics warns the user of any changes detected and produce a report that can be shared with an appropriate medical professional.
- Apr 2025Series B$19.8M
- Sep 2020Series A$5.3M
- Jun 2019Seed$2M
- Feb 2016Seed$2.6M
#5
Public · London, England · founded 2004 · 93 employees$10.3Mraised▾
AI-based medical image management and analysis solutions for healthcare organizations. It provides clinical trial services for drug development in the field of neurodegeneration. One of their product ASSESSSA assists in decision support to healthcare professionals. The company has two proprietary technology, TrialWire, and TrialTracker, and these are used to collect Alzheimer's patient's data across the world. Also, they have wearable sensors that allow the measurement of parameters, such as sleep, and activity.
- Nov 2024Post IPO$5.2M
- Sep 2016Post IPO$1.2M
- Mar 2016Grant (prize money)$137.8K
- Jan 2016Grant (prize money)$314.9K
#6
Seed · Manchester, England · founded 2020$162Kraised▾
Developer of AI-powered decision support tools for blood cancer diagnosis. It offers machine learning technology that integrates with existing digital pathology infrastructure to improve pathology services. The AI software helps to minimize turnaround times, reduce pathologists’ hands-on time, and improve the objectivity of assessments. The technology detects cancer, differentiates cell types, performs automated cell counts and spatial analyses, quantifies heterogeneity, and discovers novel molecular biomarkers for patient risk stratification. It combines insights from multi-modal datasets.
- Mar 2026Seed$1.9M
- Apr 2025Seed$483.9K
- Jul 2024Seed$162K
#7
Seed · Glasgow, Scotland · founded 2021 · 10 employees$2.3Mraised▾
Developer of magnetic sensing technology for next-generation wearable systems. The company uses magnetic sensing technology has potential applications in healthcare and can detect the magnetic fields generated by the muscles and the heart.
- Apr 2025Seed$8M
- Sep 2023Seed$2.3M
#8
Seed · Silverstone, England · founded 2024$1Mraised▾
Developer of a software platform for streamlining laboratory research and data. The platform unites research projects, lab operations, and scientific data. It offers tools for project management, sequence design, and in-lab process standardization. The platform also provides electronic lab notebook capabilities and inventory management.
- Jul 2025Seed$1M
#9
Series C · London, England · founded 2011 · 68 employees$80.3Mraised▾
Developer of software for automating biological experiments and data analysis. This platform enables the design and execution of multivariate experiments to generate structured datasets. It integrates with laboratory hardware to manage experimental workflows and standardize data collection. The software assists in assay development, media optimization, and purification processes by facilitating the management of experimental variables.
- Nov 2021Series C$35M
- Dec 2018Series B$25.6M
- May 2018Series A$3.1M
- Sep 2017Series A$10.1M
#10
Series A · Oxford, England · founded 2017 · 20 employees$18.9Mraised▾
Developer of technology for cardiac disease risk assessment and analysis. The company provides tools for preventive screening, disease diagnosis, and intervention planning. It supports drug clinical trials and clinical research. The technology analyzes inflammation related to cardiac issues.
- Apr 2023Series A$16.3M
- Mar 2021Series A—
- Mar 2021Grant (prize money)$639.7K
- Oct 2018Seed$2.6M
#11
Series A · Oxford, England · founded 2015 · 28 employees$20.6Mraised▾
Provider of AI-based cancer diagnostics platform. The company has developed an AI-based platform to detect cancer with the help of big data and image analysis. Its platform identifies different symptoms with the help of machine learning and medical imaging data. The company claims that its platform helps the clinician to identify cancer in initial stage which helps the patient to get proper treatment as per diagnostics results.
- Sep 2022Series A$14M
- Jul 2019Seed$1.3M
- Apr 2019Seed$4.1M
- May 2017Seed$1.2M
#12
Seed · London, England · founded 2022$1.2Mraised▾
Platform to capture and share lab work reproducibly. It is a platform that provides the space and tools for users to design and share lab experiments. It converts lab experiment descriptions into a structured format, automatically filling in missing details.
- Jul 2024Seed$1.2M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Clinical Labs IT coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.